Sarah Rosanel, M.D.
NPI 1043673361ActiveIndividual· Internal Medicine, Cardiovascular Disease· Surfside, FL
Opted out of Medicare from October 2025 to October 2027. Internal Medicine, Cardiovascular Disease (M.D.) in Surfside, Florida, licensed in FL and NY, with an NPI issued in April 2016. Their prescriptions cost Medicare Part D more than their services did: $82,373 for 703 claims, against $17,933 paid for services in 2024. Lexicon Pharmaceuticals, Inc. was the largest of 4 companies reporting payments in 2025, $519.71 in all, mostly food and beverage.
Overview
| NPI | 1043673361 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Apr 4, 2016 |
| Last updated in NPPES | Oct 21, 2025 |
| Certified by provider | Oct 21, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | 153324 | FL |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 300477 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Oct 1, 2025 – Oct 1, 2027 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 188 |
|---|---|
| Services billed | 309 across 13 procedure codes |
| Paid by Medicare | $17,933 |
Part D prescriptions in 2024
| Prescriptions (claims) | 703 · 1,793 30-day fills |
|---|---|
| Patients | 153 |
| Total drug cost | $82,373 |
| Generic share | 90% of claims |
Industry payments (Open Payments)
- 2025$519.71 · 8 payments from 4 companies
- 2024$518.16 · 10 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. | $158.19 | 2 |
| Janssen Biotech, Inc. | $149.86 | 1 |
| Glaxosmithkline, LLC. | $123.84 | 1 |
| Abbott Laboratories | $87.82 | 4 |
What the 2025 payments were for
- Food and Beverage$519.71 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records